Tyrosine kinase inhibitor therapy discontinuation in patients with chronic myeloid leukemia in chronic phase in the United States after clinical practice guideline updates

Ehab L Atallah, Islam Sadek, Rodrigo Maegawa, Xiting Cao, Dominick Latremouille-Viau, Irina Pivneva, Carmine Rossi, Annie Guerin, Vamsi Kota

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Tyrosine kinase inhibitor therapy discontinuation in patients with chronic myeloid leukemia in chronic phase in the United States after clinical practice guideline updates'. Together they form a unique fingerprint.

Medicine & Life Sciences